|Articles|March 21, 2017

Western IRB Establishes Single-IRB Solution

WIRB has launched a new tool designed to assist participating institutions in complying with NIH’s new single review policy for multi-site clinical trials.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Western IRB Establishes Single-IRB Solution

Newsletter

Related Content

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age

Trending on Applied Clinical Trials Online

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Accelerating Site Payments with Agentic AI: See it in Action